Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)
China · Delayed Price · Currency is CNY 30.79
-0.34 (-1.09%)
At close: Sep 11, 2026
SHA:603014 Market Cap
SHA:603014 has a market cap or net worth of 12.86 billion as of September 11, 2026. Its market cap has decreased by -22.80% in one year.
Market Cap
12.86B
Enterprise Value
10.21B
Revenue
3.76B
Ranking
n/a
PE Ratio
25.94
Stock Price
30.79
ChartMarket Cap Chart
Since May 19, 2025, SHA:603014's market cap has decreased from 17.04B to 12.86B, a decrease of -24.50%. That is a compound annual growth rate of -19.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 12.86B | -22.31% |
| Dec 31, 2025 | 16.56B | -2.82% |
| May 19, 2025 | 17.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Autobio Diagnostics | 18.36B |
| Double Medical Technology | 15.65B |
| Insight Lifetech | 12.18B |
| MeHow Innovative | 12.11B |
| Jafron Biomedical | 11.79B |
| Cofoe Medical Technology | 11.56B |
| Shanghai MicroPort Endovascular MedTech | 10.26B |
| Qingdao NovelBeam Technology | 9.68B |